Statistics

Total Visits

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)117

Select a period of time:

Number of views in the range

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)29

Views

Views
August 20252
September 20252
October 20253
November 20254
December 20257
January 202610
February 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
Brazil6
United Kingdom4
Venezuela2
Argentina1
Morocco1
Mexico1
Paraguay1
 

Top cities views

Views
Ashburn5
San Jose2
Barra do Piraí1
Bauru1
Caxias do Sul1
Chicago1
Contagem1
Jaboticabal1
Lagos de Moreno1
Lambaré1